Why Won’t My Blood Sugar Go Down With Insulin?

Insulin that fails to bring blood sugar down is almost never a problem with insulin itself being “broken” as a medicine. Instead, the issue nearly always traces to one or more interfering factors: the insulin may have degraded before you used it, the injection may not be reaching the right tissue, your body’s hormonal state may be working against the dose, or the meal you’re trying to cover may demand more insulin than you calculated. Pinpointing which of these causes applies to you usually requires some detective work, but the list of realistic culprits is surprisingly finite.

Damaged or Degraded Insulin

Insulin is a protein, and proteins are fragile. Exposure to heat, freezing, or prolonged sunlight can permanently alter the molecule’s shape, stripping it of the ability to lower blood sugar. This degradation can be physical (the proteins clump together) or chemical (the molecular bonds rearrange), and either type renders the insulin less active or completely inactive.1PubMed Central. The Effect of high temperature on the stability of basal insulin in a pen: a randomized controlled, crossover, equivalence trial The tricky part is that degraded insulin often looks the same in the vial or pen. Clear insulin that has been left in a hot car for an afternoon won’t turn a different color or smell different, but it may have lost a meaningful amount of its potency.

Practical checks are straightforward. Cloudy insulin that should be clear, or clear insulin with floating particles, is obviously compromised. But even if the appearance is normal, think about the insulin’s recent history. Was it stored in a bag during a summer outing? Left near a window? Frozen in a refrigerator’s back wall? If you’ve been using the same pen or vial for more than the manufacturer’s recommended period after opening (usually 28 to 42 days depending on the product), the insulin may have quietly lost effectiveness. Swapping in a fresh vial or pen is the single easiest troubleshooting step and eliminates one variable immediately.

Where and How You Inject

Insulin is designed to be delivered into the layer of fat just beneath the skin. When it lands somewhere else, absorption changes dramatically. If the needle goes too deep and hits muscle, absorption from the thigh can speed up by at least 50% compared to the fat layer right next to it, which sounds helpful until you realize that the faster peak is followed by a crash and then a later rise as the dose runs out too soon.2PubMed Central. Effects of accidental intramuscular injection on insulin absorption in IDDM The result is wildly unpredictable blood sugar swings rather than smooth control.

The injection site you choose also matters even when depth is correct. Insulin injected into the abdomen is absorbed roughly 86% faster than from the leg and about 30% faster than from the arm.3Annals of Internal Medicine. Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients If you normally inject into your stomach but switch to your thigh one day without adjusting timing, the insulin will arrive later than expected and you’ll see a higher post-meal spike. The post-meal glucose rise was 30 to 50 mg/dL higher after leg injection compared to abdominal injection in the same study participants.3Annals of Internal Medicine. Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients

Then there’s lipodystrophy, a condition where the fat tissue at a frequently used injection site becomes lumpy, hardened, or pitted. These tissue changes alter how insulin is absorbed from that spot, leading to erratic blood sugar control that can swing between unexplained highs and lows.4Nature. Lipodystrophy and associated factors among patients with diabetes receiving insulin therapy: a multicenter study in Ethiopia People naturally develop favorite injection spots because they’re less painful or easier to reach, but rotating sites consistently is one of the most underappreciated factors in getting insulin to work the way it’s supposed to.

High-Fat Meals and Carbohydrate Counting Errors

Most people who dose mealtime insulin base the calculation on how many carbohydrates they’re eating. That works reasonably well for simple meals, but a high-fat meal throws a wrench into the math. In a controlled study, a high-fat dinner required about 40% more insulin than a low-fat dinner with the same carbohydrate content, and even with that extra insulin, the high-fat meal still produced significantly more time spent above target.5Europe PMC. Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: implications for carbohydrate-based bolus dose calculation and intensive diabetes management Fat slows digestion and independently increases insulin resistance for hours after eating, which means the carb-only math systematically underestimates how much insulin a pizza, burger, or creamy pasta dish actually needs.

On top of that, people aren’t great at estimating carbohydrates in the first place. Research shows the average person with type 1 diabetes miscounts carbs by about 21% per meal, and roughly 63% of meals are underestimated rather than overestimated.6PubMed Central. Carbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes Larger meals tend to produce larger errors, with the biggest meals most likely to be undercounted.7PubMed Central. Modeling Carbohydrate Counting Error in Type 1 Diabetes Management So if you dosed for what you thought was 60 grams of carbs but actually ate 75, and the meal was also high in fat, you could easily see blood sugar climbing despite giving what seemed like a correct dose.

Overcorrecting a low blood sugar can also cause a rebound spike. When you feel shaky and grab juice, crackers, and a candy bar all at once, the excess carbohydrate intake during hypoglycemia drives blood sugar back up far past target.8Europe PMC. Mitigation of Rebound Hyperglycemia With Real-Time Continuous Glucose Monitoring Data and Predictive Alerts That stubborn high afterward can look like the insulin isn’t working, when really it’s a second wave of glucose from overtreatment.

Gastroparesis and the Timing Mismatch

Gastroparesis, where the stomach empties slower than normal, is a well-known but frequently underdiagnosed complication of diabetes. When food sits in the stomach longer than expected, the glucose from that meal hits the bloodstream on a delayed and irregular schedule. If you took rapid-acting insulin before eating, the insulin may peak and start wearing off before the food’s glucose even arrives, creating a pattern of early low blood sugar followed by a late, stubborn high.9PubMed Central. Diabetic gastroparesis: pathophysiology and impact on insulin timing choices This timing mismatch is especially frustrating because the total amount of insulin might actually be correct; it’s just that the insulin and the food aren’t arriving at the same time. People with gastroparesis often need to shift when they inject relative to eating, or switch to insulin types with a different action profile, which is a conversation to have with an endocrinologist.

Stress, Illness, and Hormones That Fight Insulin

Your body has several hormones whose job is to raise blood sugar. Cortisol, adrenaline (epinephrine), glucagon, and growth hormone all push glucose into the bloodstream and reduce how well your cells respond to insulin. Under stress, whether physical (an infection, surgery, an injury) or psychological (work pressure, grief, sleep deprivation), these hormones surge and can overwhelm whatever insulin dose you’re giving.10Europe PMC. Stress-Induced Diabetes: A Review

During critical illness, the effect is extreme: the combination of cortisol, catecholamines, cytokines from inflammation, glucagon, and growth hormone creates a state of profound insulin resistance that can require dramatically higher doses to manage.11Hindawi / PubMed Central. Stress hyperglycemia, insulin treatment, and innate immune cells But even everyday chronic stress can quietly raise your baseline insulin needs by 10 to 20 percent without any obvious sign that something has changed. If your blood sugar has been creeping up over weeks and you’ve also been sleeping poorly or dealing with ongoing anxiety, the connection is real.

The Dawn Phenomenon and Menstrual Cycle Effects

Many people with diabetes notice that their blood sugar is inexplicably high first thing in the morning, even if it was fine when they went to bed. This is the dawn phenomenon: in the early morning hours, your body releases a surge of cortisol, growth hormone, and catecholamines as part of its natural wake-up process. These hormones ramp up glucose production by the liver while simultaneously making your tissues less responsive to insulin.12SpringerLink. The dawn phenomenon in diabetes: pathophysiology from periphery to central nervous system and circadian rhythm-based therapeutic strategies The result is that the same basal insulin dose that holds your blood sugar steady at midnight may be inadequate at 5 a.m. For people on insulin pumps, programming a higher basal rate in the pre-dawn hours often helps. For those on injections, the timing and type of long-acting insulin may need adjusting.

Women with type 1 diabetes face an additional hormonal layer: the menstrual cycle. Insulin sensitivity drops during the luteal phase (roughly the two weeks after ovulation), and the risk of hyperglycemia increases around ovulation and into the early luteal phase compared to the early follicular phase just after a period starts.13Europe PMC. Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D If your insulin seems to stop working for a week each month and then works fine again, tracking your cycle alongside your blood sugar data can reveal the pattern. Some women adjust their insulin doses by a set percentage during those predictable high-resistance days.

Medications That Raise Blood Sugar

Several commonly prescribed medications increase blood sugar as a side effect, and corticosteroids are the most notorious. Drugs like prednisone, dexamethasone, and methylprednisolone are prescribed for asthma flares, autoimmune conditions, joint inflammation, and dozens of other situations. Even low doses of prednisolone have been shown to increase the liver’s glucose output and reduce how effectively insulin clears glucose from the blood, cutting peripheral glucose disposal meaningfully.14Europe PMC. Effects of low-dose prednisolone on hepatic and peripheral insulin sensitivity, insulin secretion, and abdominal adiposity in patients with inflammatory rheumatologic disease If you’ve recently started a steroid course or had a dose increase and your blood sugar is suddenly unmanageable, that’s the likely explanation. The effect is usually dose-dependent and fades when the steroid is tapered, but in the meantime, insulin requirements can jump substantially.

Other medications that can raise blood sugar or increase insulin resistance include certain antipsychotics (particularly olanzapine and clozapine), some beta-blockers, thiazide diuretics, and niacin at high doses. If a new medication coincides with worsening blood sugar control, it’s worth asking your prescriber whether this could be a side effect.

Insulin Resistance at the Cellular Level

When your body is exposed to consistently high levels of insulin, your cells don’t just passively absorb the message. They actively reduce the number of insulin receptors on their surface, a process sometimes described as receptor downregulation. Constant exposure to insulin triggers a negative feedback loop: the cells pull receptors back inside, making themselves less responsive to the next dose.15Europe PMC. A Receptor Story: Insulin Resistance Pathophysiology and Physiologic Insulin Resensitization’s Role as a Treatment Modality Laboratory research has demonstrated that muscle cells exposed to high insulin concentrations show a robust, dose-dependent decrease in insulin receptor protein, and this reduction was driven primarily by having fewer receptors rather than the remaining receptors working worse.16bioRxiv. Downregulation of muscle cell Insr and insulin receptor signaling by hyperinsulinemia in vitro and in vivo

This creates a vicious cycle that’s particularly relevant for people with type 2 diabetes or anyone on high insulin doses. The more insulin you need, the more your cells resist it, and the more resistant your cells become, the more insulin you need. Breaking this cycle usually requires a combination approach: changes in diet, physical activity, and sometimes medications like metformin or GLP-1 receptor agonists that improve insulin sensitivity through different pathways. Simply piling on more insulin can, paradoxically, make things worse over time.

Pump and Infusion Set Failures

For people using insulin pumps, the delivery hardware itself can silently fail. A kinked cannula, an air bubble in the tubing, a catheter that has been pulled slightly out of position, or scar tissue at the insertion site can all interrupt insulin delivery without triggering an alarm.17Europe PMC. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes What makes this particularly dangerous is that the pump’s occlusion alarm doesn’t always catch these problems. Serious adverse events can occur even when no alarm sounds, because the blockage or bend may slow insulin flow without completely stopping it.18Frontiers. Insulin infusion sets associated with adverse events: strategies for improved diabetes education

If blood sugar is climbing and correction boluses aren’t bringing it down, the standard protocol is to change the infusion set and site, then give a correction dose by syringe or pen to bypass the pump entirely. If blood sugar responds to the injected dose but not to the pump, the infusion set was the problem. Many experienced pump users keep pen insulin as a backup specifically for this scenario.

Fear of Lows and Unconscious Underdosing

Not every case of insulin “not working” is a physiological problem. Fear of hypoglycemia is pervasive among people who take insulin, and it shapes behavior in ways that aren’t always conscious. One documented pattern involves people reducing the doses their bolus calculator recommends, or stopping insulin delivery when their glucose is trending downward even though it’s still above target.19PubMed Central. Fear of hypoglycemia—An underestimated problem Over time, this protective underdosing becomes habitual. The person genuinely believes they’re giving the right amount of insulin, but their fear has nudged every dose slightly lower than it should be.

This is an understandable response. Severe hypoglycemia is frightening and sometimes dangerous, and once someone has experienced it, the psychological imprint can last years. But the cumulative effect of systematic underdosing is chronic hyperglycemia that looks, from the outside, like insulin resistance. If you find yourself frequently overriding your pump’s suggestions downward, or routinely giving less than your correction factor would indicate, the issue may be behavioral rather than biological. Working with a diabetes psychologist or a specialized educator can help separate appropriate caution from fear-driven underdosing.

Anti-Insulin Antibodies

In rare cases, the immune system produces antibodies that bind to injected insulin and prevent it from working normally. These antibodies can act as a sponge, soaking up insulin in the bloodstream and then releasing it unpredictably, causing a roller coaster of highs and lows that don’t respond to normal dose adjustments. In a study of people with insulin-treated diabetes and unexplained erratic blood sugar, researchers identified a subset whose immunoreactive insulin levels were extremely elevated and dropped by more than half after a precipitation test designed to detect antibody-bound insulin, confirming that antibodies were sequestering a significant portion of their injected dose.20PubMed Central. Diagnosis and treatment of anti‐insulin antibody‐mediated labile glycaemia in insulin‐treated diabetes

This condition, sometimes called insulin autoimmune syndrome or exogenous insulin antibody syndrome depending on the context, is genuinely uncommon. But it’s worth knowing about because it can masquerade as standard insulin resistance for months or years before anyone thinks to test for it. A hallmark clue is wild, unexplained swings between very high and very low blood sugar despite consistent dosing and diet. Treatment can involve switching to a different insulin formulation (since antibodies may be specific to one type), immunosuppressive therapy, or in some cases, plasmapheresis to physically remove the antibodies.

When Multiple Factors Stack Up

In practice, insulin that “doesn’t work” is rarely explained by a single factor. A person dealing with moderate insulin resistance from weight gain might also be injecting into lipodystrophic tissue, eating higher-fat meals than their carb ratio accounts for, and experiencing the dawn phenomenon every morning. Each factor alone might add 20 or 30 mg/dL to their readings, but stacked together they create blood sugars that seem completely unresponsive to insulin. The troubleshooting process works best when approached systematically: start with the simplest fixes (fresh insulin, correct injection sites and technique) and then layer in the less obvious variables (meal composition, medication interactions, hormonal patterns, stress) one at a time. A continuous glucose monitor makes this detective work far more practical, because it turns invisible patterns into visible data that you and your care team can actually act on.